Overview

Merozoite Surface Protein 1 Antibody Response in Asymptomatic Human Malaria Infection

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
The main purpose of this trial is to study whether a certain blood test can reliably identify the presence of malaria in people who have been infected with, but who do not have symptoms of malaria.
Phase:
N/A
Details
Lead Sponsor:
U.S. Army Medical Research and Development Command
Collaborator:
Walter Reed Army Institute of Research (WRAIR)
Treatments:
Antibodies
Immunoglobulins
Mefloquine